المؤلفون: Meng X, Al-Attar Z, Yaseen FS, Jenkins R, Earnshaw C, Whitaker P, Peckham D, French NS, Naisbitt DJ, Park BK

المصدر: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2018 Mar 01; Vol. 200 (5), pp. 1952. Date of Electronic Publication: 2018 Feb 02.

نوع المنشور: Journal Article; Published Erratum

بيانات الدورية: Publisher: American Association of Immunologists Country of Publication: United States NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: PubMed not MEDLINE

المؤلفون: Meng X; Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, The University of Liverpool, Liverpool L69 3GE, United Kingdom; and., Al-Attar Z; Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, The University of Liverpool, Liverpool L69 3GE, United Kingdom; and., Yaseen FS; Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, The University of Liverpool, Liverpool L69 3GE, United Kingdom; and., Jenkins R; Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, The University of Liverpool, Liverpool L69 3GE, United Kingdom; and., Earnshaw C; Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, The University of Liverpool, Liverpool L69 3GE, United Kingdom; and., Whitaker P; Regional Adult Cystic Fibrosis Unit, St James's Hospital, Leeds LS9 7TF, United Kingdom., Peckham D; Regional Adult Cystic Fibrosis Unit, St James's Hospital, Leeds LS9 7TF, United Kingdom., French NS; Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, The University of Liverpool, Liverpool L69 3GE, United Kingdom; and., Naisbitt DJ; Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, The University of Liverpool, Liverpool L69 3GE, United Kingdom; and., Park BK; Medical Research Council Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, The University of Liverpool, Liverpool L69 3GE, United Kingdom; and bkpark@liv.ac.uk.

المصدر: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2017 Jun 01; Vol. 198 (11), pp. 4217-4227. Date of Electronic Publication: 2017 Apr 24.

نوع المنشور: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association of Immunologists Country of Publication: United States NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphocyte Activation*, Anti-Bacterial Agents/*immunology , CD4-Positive T-Lymphocytes/*immunology , Drug Hypersensitivity/*immunology , Epitopes/*immunology , Haptens/*immunology , beta-Lactams/*immunology, Adult ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/pharmacology ; Antigens/immunology ; CD4-Positive T-Lymphocytes/physiology ; Epitopes/chemistry ; Female ; Haptens/administration & dosage ; Haptens/chemistry ; Haptens/metabolism ; Humans ; Immune Tolerance ; Male ; Mass Spectrometry ; Piperacillin/administration & dosage ; Piperacillin/immunology ; Piperacillin/metabolism ; Serum Albumin/chemistry ; Serum Albumin/immunology ; Young Adult ; beta-Lactams/administration & dosage ; beta-Lactams/metabolism

المؤلفون: Yaseen FS; Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom., Saide K; Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom., Kim SH; Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom; Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea., Monshi M; Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom., Tailor A; Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom., Wood S; Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom., Meng X; Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom., Jenkins R; Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom., Faulkner L; Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom., Daly AK; Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne, United Kingdom., Pirmohamed M; Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom., Park BK; Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom., Naisbitt DJ; Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom. Electronic address: dnes@liv.ac.uk.

المصدر: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2015 Aug; Vol. 136 (2), pp. 474-6.e8. Date of Electronic Publication: 2015 Apr 22.

نوع المنشور: Letter

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Bacterial Agents/*adverse effects , CD4-Positive T-Lymphocytes/*drug effects , CD8-Positive T-Lymphocytes/*drug effects , Chemical and Drug Induced Liver Injury/*pathology , Haptens/*adverse effects, Amoxicillin/adverse effects ; Antigen-Presenting Cells/drug effects ; Antigen-Presenting Cells/immunology ; Antigen-Presenting Cells/pathology ; B-Lymphocytes/drug effects ; B-Lymphocytes/immunology ; B-Lymphocytes/pathology ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/pathology ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/pathology ; Chemical and Drug Induced Liver Injury/etiology ; Chemical and Drug Induced Liver Injury/genetics ; Chemical and Drug Induced Liver Injury/immunology ; Clavulanic Acid/adverse effects ; Clone Cells ; Floxacillin/adverse effects ; Gene Expression ; HLA Antigens/genetics ; HLA Antigens/immunology ; Humans ; Lymphocyte Activation/drug effects

المؤلفون: Jenkins RE; MRC Centre for Drug Safety Science, Department of Pharmacology, The University of Liverpool, Sherrington Building, Ashton Street, Liverpool L69 3GE, England., Yaseen FS, Monshi MM, Whitaker P, Meng X, Farrell J, Hamlett J, Sanderson JP, El-Ghaiesh S, Peckham D, Pirmohamed M, Park BK, Naisbitt DJ

المصدر: Chemical research in toxicology [Chem Res Toxicol] 2013 Jun 17; Vol. 26 (6), pp. 963-75. Date of Electronic Publication: 2013 May 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 8807448 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5010 (Electronic) Linking ISSN: 0893228X NLM ISO Abbreviation: Chem Res Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Cystic Fibrosis/*drug therapy , Drug Hypersensitivity/*immunology , Haptens/*chemistry , Hypersensitivity/*immunology , Serum Albumin/*chemistry , T-Lymphocytes/*immunology , beta-Lactamase Inhibitors/*immunology , beta-Lactams/*immunology, Aztreonam/chemistry ; Aztreonam/immunology ; Cystic Fibrosis/complications ; Cystic Fibrosis/immunology ; Drug Hypersensitivity/complications ; Haptens/immunology ; Humans ; Hypersensitivity/complications ; Meropenem ; Molecular Structure ; Piperacillin/chemistry ; Piperacillin/immunology ; Thienamycins/chemistry ; Thienamycins/immunology ; beta-Lactamase Inhibitors/chemistry ; beta-Lactamase Inhibitors/therapeutic use ; beta-Lactams/chemistry ; beta-Lactams/therapeutic use